The efficacy of rimegepant for the acute treatment of vestibular migraine
Abstract Introduction This study aimed to observe the efficacy and safety of rimegepant, a small-molecule calcitonin gene-related peptide (CGRP) receptor antagonist, for the acute treatment of vestibular migraine (VM). Methods Patients meeting the diagnostic criteria for VM or probable VM received r...
Gardado en:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Nature Portfolio
2026-02-01
|
| Series: | Scientific Reports |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1038/s41598-026-39902-9 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|